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Abstract 
Diabetes Mellitus (DM) is a global public health epidemic characterized by the inability of the 
body to properly regulate blood glucose and can manifest in different forms. A variety of risk 
factors, such as obesity, family history and a high-caloric diet, increase the risk of developing 
Type II DM. Recently, environmental exposures, including inorganic arsenic (iAs), cadmium 
(Cd) and manganese (Mn) have been associated with diabetes and altered glucose 
homeostasis. Previous research from our lab has shown that while iAs, Cd and Mn impair 
glucose stimulated insulin secretion (GSIS) in rat insulinoma (beta) cells, they may be operating 
through different mechanisms which remain unknown. MicroRNAs, which are short, non-coding 
RNA molecules that regulate gene expression post-transcriptionally, have recently emerged as 
a candidate link between metal exposure and the development of diabetes. The goal of the 
present study was to evaluate iAs, Cd or Mn exposure on insulin response in rat insulinoma 
cells and their association with dysregulated miRNA expression. As anticipated, 24-hour 
exposure to a non-cytotoxic concentration of iAs (1 µM) inhibited GSIS by nearly 50%, while 
non-cytotoxic concentrations of Cd (5 µM) and Mn (25 µM) inhibited GSIS by more than 50%. 
These same metal exposures did not have the same effect on the three probed microRNAs 
(miR-29b, miR-146a, miR-217), which suggests each metal may be operating in a unique way. 
Small RNA sequencing revealed that these exposures resulted in a unique miRNA profile, with 
all of the exposures sharing a set of miRNAs found to be highly enriched in pancreatic islets and 
specifically β-cells. By combining sequencing data with in vitro techniques, we have begun to 
investigate the relationship between heavy metal exposure, miRNAs, and impaired insulin 
secretion.  
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Chapter 1: Introduction 
1.1 Type 2 Diabetes overview  
According to the American Diabetes Association, 29.1 million Americans suffer 
from diabetes at a cost of $ 245 billion annually (ADA 2016). This serious, costly, but 
manageable disease is a public health epidemic. Diabetes manifests in different ways 
with type 2 diabetes mellitus (T2D) being the most common form of diabetes. This 
disease centers around insulin, a hormone released by the β-cells within the Islets of 
Langerhans of the pancreas that signals cells to absorb and/or metabolize glucose. 
Glucose is used for energy or stored, and if cells cannot properly take up glucose, then 
energy imbalance and cellular dysfunction will occur. When fat, liver and muscle cells 
do not respond to insulin properly, a condition called insulin resistance, glucose is 
unable to enter the cells and builds up in the blood causing individuals to become 
hyperglycemic (“Standards” 2015). Insulin resistance can develop over time where more 
and more insulin is required to maintain glucose homeostasis (“Standards” 2015). T2D 
is a multifactorial disease where both genetic and environmental factors play a role. The 
presence of certain alleles in multiple genes and a disease-conducive environment have 
been shown to be instrumental in the development of the disorder (Murea, Ma, & 
Freedman, 2012). Since T2D is strongly linked to obesity, sedentary lifestyle and a high-
caloric diet are also conducive to the development of T2D (Murea, Ma, & Freedman, 
2012). A relatively newer area of research is surrounding the role of environmental 
toxicants and endocrine disruptors, such as inorganic arsenic (iAs), Cadmium and 
Manganese, in the development of T2D (Navas-Acien et al., 2006).  
1.2 Arsenic  
9 
Arsenic is a naturally occurring metalloid found in both organic and inorganic 
forms, with the inorganic form (iAs) being the predominant form of arsenic found in 
surface and underground water reservoirs (Paul et al., 2007). The most common route 
of exposure of iAs is through contaminated drinking water, and many countries such as 
Bangladesh, China, India, Mexico and America have high levels of iAs in their 
groundwater (“WHO” 2016). The EPA and WHO regulate arsenic in drinking water to 10 
µg/L or 10 ppb (“WHO” 2016). It is estimated that more than 50 million individuals in 
Bangladesh and 13 million residents of the United States are exposed to concentrations 
of iAs in drinking water at or above 10 ppb (BGS and DPHE, 2001; Focazio et al., 
1999). Dietary sources of arsenic exposure can include fish, meat, poultry and dairy 
products. However, dietary exposure of arsenic from these foods is generally much 
lower than exposure from contaminated drinking water (“WHO” 2016).  Arsenic is 
currently an established risk factor for cancers, cardiovascular diseases, and 
neurological disorders (Hou, Wang, & Baccarelli, 2011). The link between arsenic and 
T2D, however, has been less studied. Exposure to arsenic in contaminated drinking 
water above 100 ppb is associated with an increased risk of T2D in Taiwan and 
Bangladesh (Lai et al. 1994; Rahman et al. 1998). An expert review panel from the 
National Toxicology Program (NTP) in 2011 concluded with support for an association 
between inorganic arsenic and diabetes in areas where arsenic drinking water levels 
exceeded 500 µg/L (Maull et al. 2012). One study found that the methylated metabolites 
of iAs, methylarsonite (MAsIII) and dimethylarsinite (DMAsIII), are more potent inhibitors 
of GSIS in murine pancreatic islets. Furthermore, since arsenic exposure had little to no 
effects on insulin content, arsenic exposure may be interfering with mechanisms that 
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are responsible for insulin secretion. Consequently, the authors of this study concluded 
that insulin-producing β-cells are a target for arsenic exposure (Douillet et al., 2013).   
1.3 Cadmium  
Cadmium (Cd) is a naturally occurring toxic metal that is mainly found in the 
Earth’s crust. Since this non-essential metal exhibits a high rate of soil-to-plant transfer, 
human exposure occurs primarily through food ingestion and tobacco smoke inhalation 
(Wu et al, 2017). The main targets of cadmium intoxication include the kidneys, liver, 
bones, respiratory and reproductive systems. Cadmium has been primarily considered a 
nephrotoxicant, however, recent human and animal studies have suggested an 
association between exposure and dysregulation of glucose homeostasis (Wu et al, 
2017). An epidemiological study found that 31 to 60 year old diabetic males in Pakistan 
had significantly higher blood and urinary levels of Cd than non-diabetic males 
(Edwards et al, 2009) and these differences were maintained in both smoker and non-
smokers. Another study investigated the accumulation of cadmium in pancreatic β-cells 
and found that Cd was rapidly taken up in pancreatic tissue. Furthermore, they found 
that low levels of Cd exposure (5 µM) resulted in an increased rate of GSIS, while high 
levels of Cd exposure (20 µM) resulted in a significant decrease in insulin release 
(Nilsson et al., 1986). A review article (Edwards et al., 2009) stated that there is a direct 
effect of Cd exposure on the pancreas and there is evidence that Cd alters insulin 
release from pancreatic β-cells. They concluded that the results from both human and 
animal studies suggest an association between Cd exposure and the development of 
diabetes and diabetes-related kidney disease (Edwards et al., 2009).  
1.4 Manganese  
11 
Manganese (Mn) is an essential trace metal that is found in both plant and 
animal matter. Food is the most common route of Mn exposure in the general 
population. The Institute of Medicine sets a tolerable upper intake level for Mn at 11 
mg/day for adults. Manganese intake from drinking water is significantly lower than food 
intake at 20 ug/day, assuming a daily water intake of 2 liters. Manganese can exist in 11 
different oxidation states, with Mn2+, Mn4+ and Mn7+ being the most important 
environmental forms. Mn2+ is the predominant form found in water at a pH of 4-7 (WHO 
2016). Manganese aids the human body in the formation of connective tissue, bones 
and blood-clotting factors. It is primarily stored in bones, liver, kidney and pancreas 
(Mason 2018). A cross-sectional study based on the Korean National Health and 
Examination survey measured blood manganese levels in 3996 participants over the 
age of 20. They found blood manganese levels were significantly lower in the diabetic 
group as compared to the non-diabetes group (Koh et al, 2014). The study suggests 
that blood manganese levels may play a role in glucose homeostasis. Similarly, Kazi et 
al., 2008 performed a case-control study of 257 type 2 diabetic and 166 non-diabetic 
controls and found that diabetic patients had significantly lower blood levels of 
manganese. However, another case-control study of 250 diabetic and non-diabetic 
individuals revealed that the type 2 diabetic individuals had significantly higher serum 
levels of manganese than non-diabetic individuals (Ekin et al, 2003). Although these 
studies show conflicting results, they do suggest an association between serum 
manganese levels and glucose homeostasis.  
1.5 Mechanistic Link - MicroRNAs  
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MicroRNAs may offer a mechanistic link between increased exposure to 
inorganic arsenic, cadmium or manganese and the development of diseases such as 
T2D. MicroRNAs are short, non-coding RNA molecules that regulate gene expression 
post-transcriptionally (Vrijens et al., 2015). They function as negative regulators through 
silencing and/or suppressing gene expression (Hou et al., 2011). Research has shown 
that, “miRNAs are involved in the regulation of gene expression through the targeting of 
mRNAs during cell proliferation, apoptosis, the control of stem cell self renewal, 
differentiation, metabolism, development, and tumor metastasis” (Hou et al., 2011). 
Although the mechanism by which environmental exposures affect miRNA expression is 
unknown, there are hypothesized models that center around inflammation and oxidative 
stress, which are implicated in the pathophysiology of various diseases including 
cancer. Increased oxidative stress and the triggering of inflammatory responses by 
environmental chemicals may be the cause of alterations in miRNA expression (Hou et 
al, 2011). Recently, miRNAs have been investigated for their role in the diabetic 
phenotype. Poy et al., in 2004 was one of the first to establish a role for miRNAs in the 
regulation of insulin secretion. Since then, dozens of miRNAs have been identified as 
key players in pathways contributing to the development of type 2 diabetes, which 
include miR-146a, miR-217 and miR-29b.  
1.5.1 miR-146a  
MicroRNA-146a has been found to be highly expressed in many cell types under 
homeostatic conditions (Alipoor et al, 2017). Rong et al., 2013 discovered that 
circulating miRNA-146a levels were significantly elevated in new T2D patients as 
compared to healthy controls. Additionally, they found that circulating miRNA-146a 
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levels were positively correlated with plasma concentrations of protein Heme oxygenase 
1 (HO-1). HO-1 exerts an anti-inflammatory and anti-oxidant role on many physiological 
processes. HO-1 activity has been found to increase more than 100 fold in the presence 
of cadmium (Trakshel et al., 1986). Arsenic has also been shown to induce the activity 
and expression of HO-1 (Brown et al, 1997). It is hypothesized that chronic inflammation 
plays an important role in the development of insulin resistance and complications of 
diabetes such as neuropathy. MiR-146a is a regulator of the toll like receptor signaling 
pathway in the innate immune system (Alipoor et al, 2017). Consequently, reduced 
expression levels of miR-146a could lead to a less effective inhibition of the target 
genes involved with toll like receptors leading to dysregulation of the inflammatory 
pathway. Studies have also shown an interaction between miR-146a and interleukin-1 
receptor-associated kinase 1/TNF receptor-associated factor 6, which would decrease 
the inflammatory cytokines production in macrophages (Alipoor et al, 2017). 
Additionally, Balasubramanyam et al., 2011 revealed that impairment of miR-146a and 
its downstream signals leading to inflammation and insulin resistance in type 2 diabetes.  
1.5.2 miR-217  
Cadmium responsive microRNAs in Daphnia pulex, a widely used toxicological 
model, revealed a significant network of Cd-responsive microRNAs in relation to insulin 
metabolism. Reduced insulin levels were found to decrease the activity of transforming 
growth factor beta 1 (TGFB1), which results in the down-regulation of miR-217 (Chen et 
al, 2015). Beckman et al., 2011 co-transfected miR-217 with miR-377, which 
significantly reduced Heme oxygenase-1 protein expression and enzyme activity as 
compared to the control in HEK 239 cells. As stated previously, HO-1 exerts an anti-
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inflammatory and anti-oxidant role on many physiological processes. However, 
transfection of either miR-217 or miR-377 by themselves did not significantly reduce 
HO-1 expression level (Beckman et al, 2011). The development of diabetes can lead to 
liver and kidney impairment. Shao et al., 2016 investigated the correlation between 
serum miR-217 levels and the severity of diabetic kidney disease. They found that 
serum miR-217 levels were significantly higher in type 2 diabetic patients as compared 
to the control suggesting an involvement of miR-217 in pathways relating to the 
progression of kidney disease.  
1.5.3 miR-29b  
MiR-29b is widely studied microRNA with an established role in insulin signaling. 
The miR-29 isoforms are highly expressed in pancreatic islets. Pullen et al., 2011 
determined that miR-29b selectively targets both human and mouse Monocarboxylate 
Transporter 1 (MCT1) 3’ untranslated regions, leading to silencing of the MCT1. MCT1 
allows for circulating pyruvate and lactate to enter β-cells, where they can act as 
substrates for Krebs cycle, providing NADH and FAD for oxidative phosphorylation and 
ATP synthesis. The increased cytosolic ATP/ADP ratio resulting from this oxidation can 
trigger insulin release, even in the absence of elevated blood glucose. Therefore, it is 
likely that maintaining miR-29b expression is required for normal stimulation of insulin 
secretion by glucose (Pullen et al, 2011). He et al., 2007 studied microRNA expression 
profiles from normal Wistar and diabetic Goto-Kakizaki rats, and a microarray analysis 
of skeletal muscles revealed four upregulated and eleven down-regulated microRNAs. 
Of particular interest is microRNA-29, which was confirmed to have elevated expression 
levels in the muscle, fat and liver tissues of diabetic rats. Overexpression of microRNA-
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29 could repress insulin-stimulated glucose uptake as the muscle, fat and liver tissues 
are important targets for insulin action (He, Zhu, Gupta, Chang, & Fang, 2007).  
1.6 Small RNA sequencing  
Previous research has revealed significant expression level changes of miR-29b 
146a and 217 with 24 hour iAsIII exposure (1 µM) in INS-1 cells (Beck, unpublished 
2017) and these same microRNAs were probed through quantitative RT-PCR with Cd 
and Mn exposure. While a focus on a small subset of miRNAs allows us to associate 
each miRNA to a specific functionality, there is still a need to assess global changes in 
the expression of all miRNA genome-wide. High throughput sequencing of small RNAs 
allows for an unbiased examination of the differential expression levels of all microRNAs 
in a sample. With small RNA sequencing, we can better understand how iAs, Cd and 
Mn are affecting microRNAs and identify novel species for future targeted studies.  
Chapter 2: Materials and Methods 
2.1 Cell Culture and Treatment 
Rat insulinoma cells expressing human pre-proinsulin, INS-1 (832/13) cells with 
passage numbers from 49-60 were cultured at 5% CO2, 37°C in RPMI 1640 medium 
supplemented with 10% FBS, 10 mM HEPES, 2 mM L-Glutamine, 1 mM Sodium 
Pyruvate, 100 U/ml penicillin, 100 mg/ml streptomycin (all from Gibco, Waltham, MA), 
and 0.05 mM b-mercaptoethanol (Sigma, St. Louis, MO). INS-1 cells were exposed to 
iAsIII (1 µM), CdCl2 (5 µM) or MnCl2 (25 µM) (all from Sigma-Aldrich, St. Louis, MO) for 
24 hours. These concentrations significantly inhibited GSIS, while also being non-
cytotoxic to INS-1 cells (Dover, unpublished work 2017).  
2.2 Glucose Stimulated Insulin Secretion (GSIS) 
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INS-1 cells were then plated in a 12 well plate at 1,000,000 cells/well 24 hours prior to 
treatment. The cells were then exposed for 24 hours to iAsIII (1 µM), CdCl2 (5 µM) or 
MnCl2 (25 µM). GSIS was measured after exposure in secretion assay buffer (SAB) 
containing 114 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1.16 mM MgSO4, 20 mM 
HEPES, 2.5 mM CaCl2, 0.2% bovine serum albumin, and 25.5 mM NaHCO3. Cells were 
first incubated in 0 mM glucose SAB for 40 minutes, followed by incubation in 2.5 mM 
glucose SAB for 1 hour and by a final incubation in 16.7 mM glucose SAB for 2 hours. 
Culture medium was collected after the 2.5 mM glucose SAB and 16.7 mM glucose 
SAB incubations. The insulin secreted into the medium was measured using a Ultra 
Sensitive Mouse Insulin ELISA kit (Chrystal Chem). The amount of insulin was 
normalized for cellular protein content using a bicinchoninic acid assay (BCA).  
2.3 RNA Isolation and Quantitative RT-PCR  
Total RNA was isolated using the Norgen Total RNA kit (Norgen Biotek, Thorold, 
Canada) as per the manufacturer's instructions. Nanodrop 2000 was used to quantify 
RNA. TaqMan microRNA reverse transcription kit (Applied Biosystems) and high 
capacity RNA to cDNA kit were used as per the manufacturer’s instructions to generate 
complementary DNA for miRNA assays. RT-PCR was performed using TaqMan 
Universal PCR Master Mix (Applied Biosystems) for miRNA RT-PCR. RT-PCR assays 
were run on a Bio-Rad CFX96 Touch real time PCR detection system (Bio-Rad). The 
assays were performed in triplicate using either U6 as an internal control to measure 
miRNA expression. All TaqMan assays were purchased from Applied Biosystems and 
include: miR-29b (assay 002082), miR-146a (assay 462788), miR-217 (assay 462171), 
U6 (assay 001973).  
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2.4 Small RNA-sequencing 
High-quality RNA available from INS-1 832/13 cells exposed to arsenic, cadmium or 
manganese was used for small RNA sequencing (smRNA-seq) at Genome Sequencing 
Facility (GSF) in the Greehey Children’s Cancer Research Institute (GCCRI) of UT 
Health Sciences Center at San Antonio (UTHSCSA). Libraries were created using 
TriLink’s CleanTagTM Small RNA Library Preparation Kit for Illumina, and 50 bp single-
read sequencing was carried out on the Illumina HiSeq platform resulting in an average 
of over 10 million reads per sample. miRquant 2.0 (Kanke et al, 2016) was used to trim 
off adapter sequences, align reads to the rat genome (rn4), and quantify miRNAs and 
their isoforms (termed isomiRs). Reads were normalized to reads per millions mapped 
to miRNAs (RPMMMs). An expression threshold of at least 50 RPMMMs was set to 
filter out the lowly expressed miRNAs, which resulted in a set of 285 robustly expressed 
miRNAs.  
 
Chapter 3: Results  
3.1 Effects of Metal Exposure on GSIS  
A GSIS was performed on INS 832/13 cells after 24 hour exposure to iAs (1 µM), Cd (5 
µM) and Mn (25 µM) to assess the effects of these heavy metals on insulin secretion. 
Insulin response, i.e., insulin excreted from the cells into the medium, was measured in 
untreated cells after 1 hour incubation in 2.5 mM glucose SAB and after 2 hour 
incubation in 16.7 mM glucose SAB. As expected, the insulin response of untreated 
cells increased nearly 10x after incubation in 16.7 mM glucose SAB. Figure 1 also 
displays insulin response of heavy metal exposure after the 2 hour incubation in 16.7 
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mM glucose SAB. As expected, exposure to 1 µM iAs resulted in a nearly 50% decline 
in insulin secretion from 0.3 ng/ug to 0.17 ng/ug. Exposure to 5 µM Cd and 25 µM Cd 
also resulted in significant declines in insulin secretion, with both metals inhibiting GSIS 
by over 50%. These results are consistent with past literature and the decline in insulin 
secretion is statistically significant for all treatment groups.  
 
Figure 1. INS 832/13 cells exposed to 24 hour treatment of iAsIII (1 µM), CdCl2 (5 µM) or 
MnCl2 (25 µM). Insulin secretion was measured after incubation for 40 minutes in 0 mM 
glucose SAB, 1 hour in 2.5 mM glucose SAB and 2 hours in 16.7 mM glucose SAB. 
Values are expressed as mean ± SD for N=6 and (**) indicates statistically significant (p 
< 0.01) effects of exposure compared to control insulin secretion. 
 
3.2 Effects of metal exposure on miR-29b expression   
** ** 
** 
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Real time PCR was performed to determine microRNA-29b expression level changes 
after exposure to heavy metals. Figure 2 displays the relative quantification values 
(RQV)  of miR-29b after exposure to iAs, Cd and Mn. Exposure to 1 µM iAs increased 
the relative expression level of 29b 1.28-fold, which was expected, but not statistically 
significant. Exposure to 5 µM Cd decreased the relative expression level of 29b 0.82-
fold, however, this result was not statistically significant. Exposure to 25 µM was found 
to decrease the relative expression of miR-29b 0.35-fold, which was statistically 
significant (p < 0.01).  
 
 
Figure 2. INS 832/13 cells exposed to 24 hour treatment of iAsIII (1 µM), CdCl2 (5 µM) or 
MnCl2 (25 µM). Real time PCR was performed on these cells with miR-U6 probed as 
control. Values are expressed as RQV of control ± SD for N=9-12 and (**) indicates 
** 
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statistically significant (p < 0.01) effects of exposure compared to control microRNA 
expression level changes. 
 
3.3 Effects of metal exposure on miR-217 expression   
Real time PCR was performed to determine microRNA-217 expression level changes 
after exposure to heavy metals. Figure 3 displays the relative quantification values 
(RQV)  of miR-217 after exposure to iAs, Cd and Mn. Exposure to 1 µM iAs decreased 
the relative expression level of miR-217 0.71-fold. This value is statistically significant (p 
< 0.01). The RQV of miR-217 after exposure to 5 µM Cd was relatively unchanged. 
Exposure to 25 µM was found to decrease the relative expression of miR-217 0.89-fold, 
but was not statistically significant.  
 
 
** 
*
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Figure 3. INS 832/13 cells exposed to 24 hour treatment of iAsIII (1 µM), CdCl2 (5 µM) or 
MnCl2 (25 µM). Real time PCR was performed on these cells with miR-U6 probed as 
control. Values are expressed as RQV of control ± SD for N=9-12 and (**) indicates 
statistically significant (p < 0.01) effects of exposure compared to control microRNA 
expression level changes. 
 
3.4 Effects of metal exposure on miR-146a expression   
Real time PCR was performed to determine microRNA-146a expression level changes 
after exposure to heavy metals. Figure 4 displays the relative quantification values 
(RQV)  of miR-146a after exposure to iAs, Cd and Mn. Exposure to 1 µM iAs increased 
the relative expression level of miR-146a 1.79-fold, which was significant (p < 0.05). The 
RQV of miR-146a after exposure to 5 µM Cd was relatively unchanged at 0.92-fold. 
Exposure to 25 µM Mn was found to decrease the relative expression of miR-146a 0.66-
fold, which was statistically significant (p < 0.01).  
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Figure 4. INS 832/13 cells exposed to 24 hour treatment of iAsIII (1 µM), CdCl2 (5 µM) or 
MnCl2 (25 µM). Real time PCR was performed on these cells with U6 probed as an 
internal control. Values are expressed as RQV of control (unexposed cells) ± SD for 
N=9-12. (*) indicates statistically significant (p<0.05)  and (**) indicates statistically 
significant (p < 0.01) effects of exposure compared to control microRNA expression 
level changes. 
 
 
 
3.5 Sequencing Results  
The samples sent for small-RNA sequencing include 3 unexposed controls, 3 with 
exposure to 1 µM iAs, 3 with exposure to 5 µM Cd and 3 with exposure to 25 µM Mn. 
* 
** 
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After quality control, a total of 81 million reads mapping to miRNA species were 
obtained across the twelve samples, with over 1,000 miRNAs or isomiRs identified. 
Applying an expression threshold of at least 50 RPMMMs resulted in a set of 285 
robustly expressed miRNAs, with 10 miRNAs known to be enriched in β-cells 
responsible for over 50% of the total aligned reads. (Fig. 5) Many of these most highly 
expressed miRNAs (including miR-375, miR-7-5p, miR-26a-5p and miR-30d-5p) have 
been previously described in rodent or human islets (de Candia et al., 2017; van de 
Bunt et al., 2013).  
 
 
 
 
 
 
24 
Figure 5. Results of small RNA sequencing on INS-1 832/13 cells after 24 hour 
treatment of iAsIII (1 µM), CdCl2 (5 µM) or MnCl2 (25 µM). Expression is normalized as 
reads per million miRNAs mapped.  
 
Chapter 4: Discussion  
This study is the first to characterize the miRNA profile of rat insulinoma cells in 
the context of heavy metal exposure. Furthermore, by combining sequencing data with 
in vitro techniques, we have begun to investigate the relationship between heavy metal 
exposure, miRNAs, and impaired insulin secretion.  
Previous in vitro studies conducted in our lab (Douillet et al 2013) show 
pancreatic islets exposed for 48 hours to low subtoxic concentrations of arsenic and its 
methylated metabolites display inhibited GSIS without any detrimental effect on insulin 
transcription. This leads us to believe that arsenic may have targets along the insulin 
secretory pathway, however, the exact mechanism remains unknown. Research by 
Dover et al, 2017 (unpublished) assessed the effects of iAs, Cd, and Mn on 
mitochondrial respiration, and discovered that exposure to iAs significantly impaired the 
mitochondrial oxygen consumption rate in a manner that other exposures (Cd and Mn) 
did not. The means by which iAs is exerting an effect on mitochondrial respiration, 
however, needs to be further investigated.  
iAs is of particular interest due to its prevalence in food and drinking water 
throughout the world. Arsenic levels in some private wells can reach up to 800 ppb, 
which 80 times the EPA’s regulatory limit of 10 ppb (Sanders et al., 2014). A 1 µM 
concentration of iAs used in these experiments is equivalent to 75 ppb, a physiologically 
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relevant concentration many around the world are exposed to. Exposure to 1 µM iAs for 
24 hours was enough to reduce GSIS by nearly 50%, however, iAs is just one of many 
heavy metals that have been implicated in metabolic diseases.  
Cadmium and Manganese are known human developmental toxicants that are 
also found in drinking well water (Sanders et al, 2014). 24-hour exposure of INS-1 
(832/13) cells to 5 µM Cd resulted in a 53% inhibition of GSIS. Similarly, 24-hour 
exposure of INS-1 (832/13) cells to 25 µM resulted in a nearly 70% decline in insulin 
secretion. While these non-cytotoxic concentrations of Cd and Mn have been shown to 
have no deleterious effect on cell viability or mitochondrial function (Dover, unpublished 
2017), there is a lack of data on the effect of these exposures on islet insulin content. 
Future studies need to interrogate the effects of Cd and Mn on insulin mRNA levels to 
determine if these heavy metals are disrupting the insulin production pathway.  
MicroRNAs have recently emerged as a possible mechanistic link between heavy 
metal exposure and the diabetic phenotype. Alterations in microRNAs have been shown 
to be critical in the pathophysiology of many diseases, including cancer (Calin et al, 
2006). While iAs, Cd, and Mn all cause an impairment of GSIS, they may be acting on 
different targets, and one way to investigate this is through the examination of their 
miRNA profiles.  
In this study, miRNAs 29b, 146a and 217 were probed after INS-1 832/13 
exposure to iAs, Cd or Mn. Previous research in our lab has shown a statistically 
significant increases in the expression of miR-29b and mir-146a with exposure to 1 µM 
iAs (Beck, unpublished 2017). Our lab has also shown a statistically significant 
decrease in the expression of miR-217 with exposure to 1 µM iAs (Beck, unpublished 
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2017). This study investigated these same microRNAs in the context of cadmium and 
manganese exposure. miR-29b is a widely studied microRNA with established roles in 
insulin signaling (He et al, 2007). Overexpression of miR-29b was found to inhibit 
insulin-stimulated glucose uptake in a murine insulin-responsive fat cell line. The high 
levels of miR-29 caused insulin resistance, which mimicked insulin resistance in cells 
that are incubated with high glucose and high insulin (He et al, 2007). Notably, in our 
study exposure to 1 µM iAs increased the expression of miR-29b 1.28-fold, which could 
play a role in the inhibition of GSIS. iAs exposure also resulted in a statistically 
significant decrease in the RQV of miR-217. High glucose has been shown to increase 
the expression of miR-217 in rat glomerular mesangial cells (Shao et al, 2016). 
Therefore, arsenic exposure could be affecting glucose homeostasis during conditions 
of high glucose, where the expression of miR-217 is dysregulated and unable to 
perform its normal function. iAs exposure increased the relative expression of miR-146a 
and manganese exposure decreased the relative expression of miR-146a. MiR-146a is 
a regulator of the toll like receptor signaling pathway in the innate immune system 
(Alipoor et al, 2017). Consequently, reduced expression levels of miR-146a could lead 
to a less effective inhibition of the target genes involved with toll like receptors leading to 
dysregulation of the inflammatory pathway. Chronic inflammation is hypothesized to 
play an important role in the development of insulin resistance and complications of 
diabetes such as neuropathy. Therefore, the dysregulation of the inflammatory pathway 
by reduced expression levels of miR-146a with manganese exposure could lead to the 
development of insulin resistance.  
27 
Though 24-hour exposure of iAs, Cd or Mn all significantly inhibited insulin 
response in INS-1 832/13 cells, the metals did not have the same effect on the three 
probed microRNAs which suggests that they may have different targets in the human 
body. This was further investigated through high throughput sequencing to view 
changes in small RNA species transcriptome-wide in response to iAs, Cd, or Mn 
exposure. Exposure to each metal resulted in a unique miRNA profile, though all 
exposures shared a set of miRNAs found to be highly enriched in pancreatic islets and 
specifically β-cells. None of these shared miRNAs were affected by metal exposure, but 
each metal did have a unique effect on several other miRNAs, which should be 
investigated further in future studies.  While there is no established method of 
determining the significance of a microRNA fold change (Chugh et al, 2012), functional 
studies must be performed to evaluate the effect, if any, of the microRNA on the 
biological phenotype. These studies should target highly upregulated or highly 
downregulated microRNAs from the small RNA sequencing data. Locked nucleic acids 
or LNAs can modulate gene expression by binding to specific messenger RNA, pre-
mRNA or non-mRNA through Watson and Crick base pairing (Veedu et al, 2010). They 
can be used in experiments to inhibit microRNA expression. Conversely, microRNA 
mimics can be used to up-regulate the activity of a specific microRNA. By employing 
either of these methods, one can observe any phenotypic changes that occur as result 
of inhibition or overexpression of a specific microRNA.  
Additional future studies should also assess the effects of metal mixtures on 
microRNA expression level changes. Heavy metals, such as arsenic, cadmium and 
manganese can be found together in drinking water (Buschmann et al, 2008). Studies 
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investigating metal mixtures would offer insight into whether these metals can have 
synergistic or antagonistic effects on microRNA expression levels which may further 
lead to dysregulation of diabetes-related genes.   
Regardless of whether or not any gene targets are identified, microRNAs can still 
be used as biomarkers for correlated disease phenotypes, which could be of high 
medical and commercial value (Chugh et al, 2012).  
 In summary, T2D is a global public health epidemic that continues to rise in 
prevalence. Recently, environmental exposures, including iAs, Cd and Mn, have been 
linked to the dysregulation of glucose homeostasis and diabetes. In this study, 24 hour 
exposure to non-cytotoxic concentrations of iAs, Cd or Mn all significantly inhibited 
insulin secretion in INS-1 (832/13) cells. MicroRNAs represent a possible mechanistic 
link between these environmental exposures and the development of the diabetic 
phenotype. These same metal exposures did not have the same effect on the three 
probed microRNAs (miR-29b, miR-146a, miR-217), which suggests that they may have 
different targets in the human body.  Small RNA sequencing revealed that these 
exposures resulted in a unique miRNA profile, with all of the exposures sharing a set of 
miRNAs found to be highly enriched in pancreatic islets and specifically β-cells.  
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